| Mohammad Aminul Islam, MD | |
|
3701 Loop Road East, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404-5015 | |
| (205) 554-2000 | |
| Not Available |
| Full Name | Mohammad Aminul Islam |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 3701 Loop Road East, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063621001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 30026 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Aminul Islam, MD 3701 Loop Road East, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404-5015 Ph: (205) 554-2000 | Mohammad Aminul Islam, MD 3701 Loop Road East, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404-5015 Ph: (205) 554-2000 |
News Archive
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2014.
Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, today introduced the ExactaMix 1200 Automated Compounding Device (ACD) for small- to mid-sized hospital pharmacies in need of an automated approach to compounding large-volume parenteral doses.
Nuvo Research Inc. a specialty pharmaceutical company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies and on the development of its immune modulating drug candidate WF10, today announced that its European Phase 2 clinical trial evaluating WF10 as a treatment for severe allergic rhinitis met its primary endpoint.
New research shows that seven compounds of the countless found in spider venom block a key step in the body's ability to pass pain signals to the brain. The hunt for a medicine based on just one of these compounds, which would open up a new class of potent painkillers, is now a step closer according to new research published in the British Journal of Pharmacology.
› Verified 5 days ago
Aftab M Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2201 Jack Warner Pkwy, Tuscaloosa, AL 35401 Phone: 205-343-9090 Fax: 205-860-6332 | |
Dr. Carlos Eugenio Berry, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404 Phone: 205-554-2822 | |
Dr. Patricia Diane Pilkinton, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Road East, Tuscaloosa Va Medical Center, Tuscaloosa, AL 35404 Phone: 205-554-2822 Fax: 205-554-2894 | |
Aurora Payag Trabajo, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 200 University Blvd, Tuscaloosa, AL 35401 Phone: 205-759-0799 Fax: 205-759-0845 | |
Dr. Jonathan Josef Skonicki, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3701 Loop Rd, Tuscaloosa Va Medical Center,, Tuscaloosa, AL 35404 Phone: 205-554-2000 | |
Madeleine Rachelle Moreno, MSN, PMHNP- BC (CRNP Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 750 Peter Bryce Blvd, Tuscaloosa, AL 35401 Phone: 205-348-6262 |